Business
Cochlear posts $238m loss as COVID, patent case bites – Sydney Morning Herald
Underlying profit at the hearing implant maker slid 42 per cent as coronavirus shutdowns impacted sales.
The expense brought the company’s overall net loss to $238.3 million, a 186 per cent drop on last year’s $276.7 million profit.
Cochlear shares rose 6.5 per cent to $211.28 in morning trade.
Chief executive Dig Howitt said the tough coronavirus conditions had not changed the company’s broader goals of retaining and growing market leadership for its products.
He said elective surgeries had started to flow back in key markets but Cochlear was watching closely to evaluate the impact of the pande…
-
Noosa News24 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General24 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News22 hours agoQueenslanders not out of the woods as more storms, heatwave conditions to continue after horror three days
-
Business17 hours agoBroker names 2 small cap ASX shares to buy for big returns